Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oclacitinib maleate (PF-03394197 maleate) 是一种新型JAK 抑制剂,有效抑制JAK1,IC50为 10 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 289 | 现货 | ||
2 mg | ¥ 433 | 现货 | ||
5 mg | ¥ 798 | 现货 | ||
10 mg | ¥ 1,180 | 现货 | ||
25 mg | ¥ 2,230 | 现货 | ||
50 mg | ¥ 3,970 | 现货 | ||
100 mg | ¥ 5,680 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 798 | 现货 |
产品描述 | Oclacitinib maleate (PF-03394197 maleate) is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases. |
靶点活性 | JAK1-dependent:36 to 249 nM, JAK:10 to 99 nM |
体外活性 | PF-03394197 inhibits JAK family members by 50% at concentrations ranging from 10 to 99 nM and does not inhibit a panel of 38 non-JAK kinases. PF-03394197 is most potent at inhibiting JAK1. PF-03394197 also inhibits the function of JAK1-dependent cytokines involved in allergy and inflammation as well as pruritus. PF-03394197 has minimal effects on cytokines which does not activate the JAK1 enzyme in cells[1]. |
体内活性 | PF-03394197 administered orally at a dose of 0.4–0.6 mg/kg twice daily is safe and efficacious in controlling the pruritus associated with allergic dermatitis. PF-03394197 provides itch relief within 24 h that persistes through the treatment period, with over 70% of the treated dogs achieving a >50% reduction in pruritus by day 7[2]. |
别名 | PF-03394197 maleate, 奥拉替尼马来酸盐, PF-03394197 |
分子量 | 453.51 |
分子式 | C15H23N5O2S·C4H4O4 |
CAS No. | 1640292-55-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 15 mg/mL (33.1 mM)
Ethanol: 83 mg/mL (183 mM)
DMSO: 83 mg/mL (183 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / Ethanol / DMSO | 1 mM | 2.205 mL | 11.0251 mL | 22.0502 mL | 55.1256 mL |
5 mM | 0.441 mL | 2.205 mL | 4.41 mL | 11.0251 mL | |
10 mM | 0.2205 mL | 1.1025 mL | 2.205 mL | 5.5126 mL | |
20 mM | 0.1103 mL | 0.5513 mL | 1.1025 mL | 2.7563 mL | |
Ethanol / DMSO | 50 mM | 0.0441 mL | 0.2205 mL | 0.441 mL | 1.1025 mL |
100 mM | 0.0221 mL | 0.1103 mL | 0.2205 mL | 0.5513 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Oclacitinib maleate 1640292-55-2 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors Tyrosine Kinases JAK Oclacitinib PF 03394197 PF-03394197 maleate PF-03394197 Maleate inhibit PF03394197 Maleate PF03394197 Oclacitinib Maleate Inhibitor PF 03394197 Maleate 奥拉替尼马来酸盐 PF-03394197 Janus kinase inhibitor